Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

COVID-19 (coronavirus disease 2019) is associated with heightened risks of venous and arterial thrombosis and hospitalization due to respiratory failure. To assess whether prophylactic anticoagulation can safely reduce the frequency of venous and arterial thrombosis, hospitalization, and death in no...

Descripción completa

Detalles Bibliográficos
Autores principales: Piazza, Gregory, Spyropoulos, Alex C., Hsia, Judith, Goldin, Mark, Towner, William J., Go, Alan S., Bull, Todd M., Weng, Stephen, Lipardi, Concetta, Barnathan, Elliot S., Bonaca, Marc P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270282/
https://www.ncbi.nlm.nih.gov/pubmed/37154020
http://dx.doi.org/10.1161/CIRCULATIONAHA.123.063901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270282/
https://www.ncbi.nlm.nih.gov/pubmed/37154020
http://dx.doi.org/10.1161/CIRCULATIONAHA.123.063901

Ejemplares similares